← back to search

Masoud Babaei

Tehran University of Medical Sciences · IR
Area of research
Oncology · Surgery
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Helicobacter pylori-related gastroenterology studies, Regulation of Appetite and Obesity, and Colorectal Cancer Screening and Detection.
h-index
14
citations
1,000
works
29
NIH funding
primary concept
email

Recent publications

Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
BMC Medicine 2018cited by 129position: middledoi
Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study
Clinical Epidemiology 2018cited by 13position: middledoi
Survival of resected and overall pancreatic cancer patients in Europe and USA in 2003-2014: An international large-scale population-based investigation.
Journal of Clinical Oncology 2018cited by 0position: middledoi
Administration of adjuvant chemotherapy for stage<scp>II‐III</scp>colon cancer patients: An European population‐based study
International Journal of Cancer 2017cited by 48position: firstdoi
Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes
Clinical Colorectal Cancer 2017cited by 30position: firstdoi
Minimally Invasive Colorectal Cancer Surgery in Europe
Medicine 2016cited by 26position: firstdoi
Estimating the Esophagus Cancer Incidence Rate in Ardabil, Iran: A Capture-Recapture Method
Iranian Journal of Cancer Prevention 2016cited by 14position: middledoi
Histological concordance in familial central nervous system tumors: Evidence from nationwide Swedish Family-Cancer Database
Cancer Epidemiology 2015cited by 2position: firstdoi
A Form of the Metabolic Syndrome Associated with Mutations in <i>DYRK1B</i>
New England Journal of Medicine 2014cited by 169position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

V.E.P.P. Lemmens · Netherlands Comprehensive Cancer Organisation5 papers (2016–2018)Yesilda Balavarca · Biostatistical Consulting (United States)5 papers (2016–2018)Hermann Brenner · Stanford University5 papers (2016–2018)Lina Jansen · Krebsregister Baden-Württemberg5 papers (2016–2018)Petra Schrotz‐King · German Cancer Research Center5 papers (2016–2018)Cornelia M. Ulrich · University of Utah3 papers (2016–2017)Annika Sjövall · Karolinska Institutet3 papers (2016–2017) · 3 papers (2017–2018)María José Bento · Universidade do Porto2 papers (2016–2017)Lei Huang · Nanchang University2 papers (2018–2018) · 2 papers (2016–2017)Harlinde De Schutter · Stichting tegen Kanker2 papers (2018–2018) · 2 papers (2016–2017)Bengt Glimelius · Uppsala University2 papers (2017–2017)Mahdi Fallah · University of Bern2 papers (2015–2018)Tom Børge Johannesen · The Ohio State University2 papers (2018–2018) · 2 papers (2018–2018)Kari Hemminki · Lund University2 papers (2015–2018)Vesna Zadnik · University of Primorska2 papers (2018–2018) · 2 papers (2018–2018)